Net Income (Loss) Attributable to Parent in USD of Rallybio Corp from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Rallybio Corp quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2020 to Q3 2025.
  • Rallybio Corp Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $16M.
  • Rallybio Corp Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$14.2M, a 78.8% increase year-over-year.
  • Rallybio Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$57.8M, a 22.5% increase from 2023.
  • Rallybio Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$74.6M, a 11.9% decline from 2022.
  • Rallybio Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$66.7M, a 41.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Rallybio Corp Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$14.2M $16M +$27.5M 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$41.7M -$9.7M +$6.53M +40.2% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$48.2M -$9.44M +$9.59M +50.4% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$57.8M -$11M +$9.2M +45.4% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 -$67M -$11.5M +$6.91M +37.6% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$73.9M -$16.2M +$2.39M +12.9% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$76.3M -$19M -$1.71M -9.88% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$74.6M -$20.2M -$4.04M -24.9% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 -$70.5M -$18.4M -$4K -0.02% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$70.5M -$18.6M -$1.05M -5.96% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$69.5M -$17.3M -$2.82M -19.5% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$66.7M -$16.2M -$3.79M -30.5% 01 Oct 2022 31 Dec 2022 10-K 12 Mar 2024
Q3 2022 -$62.9M -$18.4M -$8.17M -80.2% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$54.7M -$17.6M -$6.46M -58% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$48.2M -$14.5M -$1.22M -9.21% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$47M -$12.4M 01 Oct 2021 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 -$10.2M -$3.04M -42.5% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$11.1M -$6.23M -127% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$13.3M 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q3 2020 -$7.16M 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$4.89M 01 Apr 2020 30 Jun 2020 10-Q 09 Sep 2021

Rallybio Corp Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$57.8M +$16.8M +22.5% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 -$74.6M -$7.91M -11.9% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 -$66.7M -$19.6M -41.8% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024
2021 -$47M -$20.6M -77.8% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023
2020 -$26.4M 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.